Sphingolipids in Alzheimer's disease, how can we target them?

SM Crivelli; C Giovagnoni; L Visseren; AL Scheithauer; N de Wit; Sandra den Hoedt; M Losen; Monique Mulder; J Walter; HE de Vries; E Bieberich; P Martinez-Martinez

doi:10.1016/j.addr.2019.12.003

Sphingolipids in Alzheimer's disease, how can we target them?

SM Crivelli
, C Giovagnoni
, L Visseren
, AL Scheithauer
, N de Wit
, Sandra den Hoedt
, M Losen
, Monique Mulder
, J Walter
, HE de Vries
, E Bieberich
, P Martinez-Martinez

Internal Medicine

Research output: Contribution to journal › Article › Academic › peer-review

78 Citations (Scopus)

Original language	English
Pages (from-to)	214-231
Number of pages	18
Journal	Advanced Drug Delivery Reviews
Volume	159
DOIs	https://doi.org/10.1016/j.addr.2019.12.003
Publication status	Published - 2020

Research programs

EMC OR-01

Access to Document

10.1016/j.addr.2019.12.003

Cite this

@article{b16984acdc9d46e6adb96b3b28f34874,

title = "Sphingolipids in Alzheimer's disease, how can we target them?",

author = "SM Crivelli and C Giovagnoni and L Visseren and AL Scheithauer and \{de Wit\}, N and \{den Hoedt\}, Sandra and M Losen and Monique Mulder and J Walter and \{de Vries\}, HE and E Bieberich and P Martinez-Martinez",

year = "2020",

doi = "10.1016/j.addr.2019.12.003",

language = "English",

volume = "159",

pages = "214--231",

journal = "Advanced Drug Delivery Reviews",